US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.775
  • +0.021+2.80%
Close Feb 14 16:00 ET
65.85MMarket Cap-0.42P/E (TTM)

About Century Therapeutics Company

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Company Profile

SymbolIPSC
Company NameCentury Therapeutics
Listing DateJun 18, 2021
Issue Price20.00
Founded2018
CEOMr. Brent Pfeiffenberger, M.B.A.,PhD
MarketNASDAQ
Employees165
Fiscal Year Ends12-31
Address38th Street, 25 North,11th Floor
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Phone1-267-817-5790

Company Executives

  • Name
  • Position
  • Salary
  • Brent Pfeiffenberger, M.B.A.,PhD
  • Director, President and Chief Executive Officer
  • 3.24M
  • Dr. Gregory Russotti, PhD
  • Chief Technology and Manufacturing Officer
  • 2.59M
  • Dr. Adrienne Farid, PhD
  • Chief Operations Officer
  • 1.71M
  • Dr. Morgan Conn, PhD
  • Chief Financial Officer
  • --
  • Joseph Jimenez
  • Chairman of the Board
  • 197.40K
  • Dr. Hyam I. Levitsky,M.D.
  • President of Research and Development
  • --
  • Daphne E. Quimi
  • Independent Director
  • 169.65K
  • Timothy P. Walbert
  • Independent Director
  • 159.40K
  • Dr. Kimberly L. Blackwell, M.D.
  • Independent Director
  • 165.90K
  • Dr. Carlo Rizzuto, PhD
  • Independent Director
  • 168.40K
  • Dr. Alessandro Riva, M.D.
  • Independent Director
  • 161.90K
  • Cynthia M. Butitta
  • Independent Director
  • 170.65K

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More